Sarcomere relaxation depends on dissociation of actin and myosin, which is regulated by a number of factors, including intracellular [MgATP] 
Introduction
Muscle contraction and relaxation are determined by the cyclic interaction between myosin and actin. This interaction, known as cross-bridge cycling, consists of the attachment of the two proteins, a change in their conformation, and consequently the power stroke and detachment. The chemical energy used to support cross-bridge cycling is produced during MgATP hydrolysis by myosin ATPase. Studies of these proteins in solution have defined the key steps in this cyclic interaction (1, 2) .
In the absence of nucleotides, actin and myosin form a strong complex. The complex dissociates upon the binding of MgATP to myosin. Myosin hydrolyzes MgATP and the products of hydrolysis, inorganic phosphate (Pi) 1 and MgADP, are released sequentially. Pi is released when the actomyosin complex undergoes a conformational change which leads to force generation (3) . MgADP must then be released before MgATP binds, enabling the actin and myosin to enter a second cycle. Thus, any alterations at the levels of MgATP binding, myosin ATPase activity, or the subsequent release of either MgADP or Pi may affect cross-bridge cycling, resulting in abnormal contraction and relaxation. Previous studies using skinned skeletal muscle fibers showed that an increase in free [Pi] inhibits the conformational change of the actomyosin complex and thereby influences the power stroke (4, 5) . Using similar preparations, it was also shown that an increase in free [MgADP] reduced fiber velocity, possibly due to its interference with MgATP binding to myosin (6) .
The regulation of cross-bridge cycling has so far only been studied using isolated contractile proteins or skinned fibers in which only a single contraction is elicited. In most of these experiments, [MgADP] was in mM range, which is one to two orders of magnitude higher than typical physiological levels. Regulation of the rhythmic contraction at the whole organ level, and, in particular, the role of MgADP in systolic and diastolic function of an intact heart, is still lacking. We reasoned that increased free [MgADP] in an intact cell, at a concentration achievable physiologically, could decrease the rate of MgADP detachment and thus slow down the rate of crossbridge cycling, leading to an impairment of relaxation at the whole organ level.
Here we propose a strategy for testing whether this is the case for an intact beating heart: by applying a low dose of iodoacetamide (IA), a sulfhydryl group modifier, we were able to irreversibly inhibit creatine kinase (CK) without affecting other major MgATP synthesis and utilization pathways in an isolated buffer-perfused heart (7, 8) . The selective inhibition of the CK reaction blocked the primary mechanism that keeps a low free [MgADP] in the cell. Since the MgATP synthesis via oxidative phosphorylation is unaffected, this approach offers an unique method to alter free [MgADP] without changing either [MgATP] or [Pi] in a beating heart at baseline workload.
Using this approach, we tested the hypothesis that an increase in free [MgADP] may cause an increase in left ventricular end diastolic pressure (LVEDP), a measurement of myocardial relaxation in an isolated, isovolumic rat heart. To take into consideration the other regulators of cross-bridge cycling, we also measured myocardial high energy phosphate content and intracellular pH (pH i ) by 31 P NMR spectroscopy. The trigger of the cross-bridge cycling, cytosolic calcium concentration ([Ca 2 ϩ ] c ), was determined by indo-1 fluorescence measurement. Furthermore, recent evidence suggests that MgATP derived from glycolysis may play an important role in the maintenance of LVEDP (9) . Because IA treatment has been shown to inhibit glycolytic enzyme activities, we also directly measured myocardial glycolytic flux in the absence and presence of IA.
We found a dose-dependent relationship between increases in LVEDP and free [MgADP] 
Methods
Isolated perfused heart. Male Sprague-Dawley rats, weighing 375-425 g, were anesthetized by injection of 30 mg i.p. of sodium pentobarbital. Excised hearts were perfused by Langendorff mode. Briefly, aortic retrograde perfusion was maintained at a constant perfusion pressure of 100 mmHg at 37 Њ C. Adequate coronary perfusion was obtained by incision of the root of the pulmonary artery. Thebesian vein drainage was facilitated by an apical vent. A water-filled latex balloon was inserted into the left ventricle through an incision in the left atrium for constant monitoring of left ventricular pressure and heart rate. Coronary flow was measured by collection of coronary effluent from the suction tube. The perfusate contained (mM): NaCl, 118.0; KCl, 4.7; CaCl 2 , 1.75; MgSO 4 , 1.2; EDTA, 0.5; NaHCO 3 , 25.0; and glucose, 11.0 (pH 7.4 when gassed with 95% O 2 , 5% CO 2 at 37 Њ C). All hearts were allowed to equilibrate for 15-20 min when LVEDP was set at 5-10 mmHg by inflating the balloon in the left ventricle.
Four protocols were performed for this study. ] was adjusted to 1.25 mM in the perfusate used for this protocol. Hearts were paced at 5 Hz, and left ventricular pressure was measured using a solid state, high fidelity transducer (Millar Instruments Inc., Houston, TX) attached to the water-filled latex balloon. Under these conditions, LVEDP for hearts supplied with 90 mol of IA was 20 mmHg, a value similar to LVEDP for unpaced, non-dye-loaded hearts supplied with 120 mol of IA. In protocol IV, glycolytic rate was measured in hearts treated either with vehicle (H 2 O) or IA. At the end of the experiment, all hearts were freeze clamped with aluminum tongs cooled to the temperature of liquid nitrogen and stored at Ϫ 80 Њ C for biochemical assays.
31
P NMR spectroscopy. 31 P NMR spectra were obtained at 161.94
MHz on a GE-400 Omega spectrometer (GENMR Instruments, Fremont, CA). The heart was placed in an NMR sample tube and inserted into a 1 H/ 31 P double tuned probe which was situated in a 20-mm bore, 9.4 T superconducting magnet. Spectra were collected without proton decoupling at a pulse width of 27 s, pulse angle of 60 Њ , recycle time of 2.14 s and a sweep width of 6,000 Hz. Spectra were obtained by averaging the signals from 104 free induction decays during a 4-min period. Spectra were analyzed using 20 Hz exponential multiplication and zero and first order phase corrections. Each resonance peak was fitted to a Lorentzian function and the area under each peak was calculated by a commercially available program NMR1 (NMRi, Syracuse, NY). By comparing the peak areas of fully relaxed (recycle time 10 s) and those of partially saturated (recycle time 2.14 s) spectra, the correction factors for saturation were calculated for [ ␤ -P] MgATP (1.0), phosphocreatine (PCr, 1.2), and Pi (1.15).
In pilot studies, [MgATP] and total creatine [Cr] have been determined biochemically in the isolated perfused heart preparation at the end of the 20-min stabilization period. Using a value of 0.155 mg protein/mg blotted wet tissue and the reported value of 0.48 ml intracellular water/mg blotted wet tissue (10), [MgATP] and total [Cr] were calculated to be 11.7 mM and 27.4 mM respectively in these hearts (8) . This value of Cytosolic free [MgADP] was calculated using the equilibrium constant of CK reaction (11) and values obtained by NMR spectroscopy and biochemical assay:
, where K eq ϭ 1.66 ϫ 10 9 M Ϫ 1 . When the activity of an enzyme is inhibited, the rate constants for the forward and reverse reactions are both decreased, and the K eq is not altered. Thus, the equilibrium of the CK reaction is maintained even for the group of hearts with only 2% enzyme activity (0.25 IU/mg protein at 37 Њ C). The remaining CK activity is greater than the ATP synthesis rate estimated by measuring myocardial oxygen consumption (0.16 mol ATP/min per mg protein) (12) . This prediction is further supported by our previous experimental observation that [PCr] decreased significantly during high workload and recovered completely after 15 min baseline perfusion in hearts with only 1% CK activity (8) . Thus, this amount of CK is sufficient to synthesize and use PCr. It is possible that it takes a longer time to reach a new equilibrium for hearts with 2% CK activity. Based on our experience with high workload/recovery experiments, we have allowed sufficient time (30 min) for the PCr to be turned over 18 times before the 31 P NMR spectra were acquired after CK inhibition in the present study. Thus, our approach to calculate [MgADP] using CK reaction equilibrium should be valid under these experimental conditions.
Biochemical assays. Ventricular tissue (5-10 mg) was homogenized for 10 s at 4 Њ C in potassium phosphate buffer containing 1 mM EDTA and 1 mM ␤ -mercaptoethanol, pH 7.4 (final concentration of 5 mg tissue/ml). Aliquots were removed for assays of protein by the method of Lowry (13) using bovine serum albumin as the standard. Triton X-100 was then added to the homogenate at a final concentration of 0.1% for analysis of creatine kinase (CK) activity (14). The CK activity was measured in tissue homogenates at 30 Њ C for each heart reported in this study. Treatment with 30, 90, and 120 mol of IA inhibited the CK activity by 76, 95, and 98%, respectively, except as otherwise stated. The activities of the glycolytic enzymes, phosphofructokinase (PFK), glyceraldehyde 3-phosphate dehydrogenase (GAPdH) and lactate dehydrogenase (LDH), were analyzed as described in references 15-17. All enzyme activities are expressed as International Units (IU ϭ mol/min)/g of cardiac protein. All reagents used were at least analytical grade obtained from Sigma Chemical Co. ] c on the surface of perfused hearts as described in references 18 and 19. This method is based on previous work that has identified and minimized potential sources of artifact in the indo-1 technique. Specifically, the effects of motion (18) , autofluorescence (18, 19) , unhydrolyzed indo-1 AM (20) , tissue filter effect (18, 19) , potential loading of indo-1 into endothelial cells (20) , and noncytosolic compartmentation (21) Measurement of glycolytic rate. In a parallel experiment, hearts were first perfused and treated with either vehicle or 120 mol of IA as described above. After the infusion of vehicle or IA was complete, hearts were switched to a recirculating buffer perfusion system at an identical perfusion pressure of 100 mmHg at 37 Њ C. Glycolytic flux was determined by the addition of [5- 3 H]glucose (DuPont-NEN Products, Boston, MA) to a total buffer volume of 100 ml ( ‫ف‬ 14 Ci/mmol). Metabolism of [5- 3 H]glucose through glycolysis leads to release of 3 H 2 O at the enolase reaction, which is downstream of both the PFK and GAPdH catalyzed steps in glycolysis. The glycolytic rate was measured by quantifying the rate of 3 H 2 O release to the perfusate as described by Saddick and Lopaschuk (23) , and is expressed as mol of glucose/min per g protein.
Measurement of [Ca
Statistical analysis. All results were expressed as mean Ϯ standard error of the mean. Comparisons among groups were made by ANOVA using the dose of IA as a grouping factor. When significant effects were observed, a two-tailed t test was used as a post hoc test. Measurements made before and after treatment with IA were compared by repeated measures ANOVA or paired t test. All statistical analyses were performed using Statview (Brainpower Inc., Calabasas, CA) and a value of P Ͻ 0.05 was considered significant. Lower probabilities were not reported.
Results

Fig. 1 shows representative
31
P NMR spectra and difference spectra for one heart before and after treatment with 120 mol of IA and another heart before and after infusion with H 2 O (control). Infusion of H 2 O did not cause any changes in the spectra. With the highest dose of IA used in this study, there were no changes in the Pi or ATP peak areas, but there was a significant decrease in PCr peak area. The concentrations of high energy phosphates and pH i for all hearts treated with increasing doses of IA are shown in Table I Table II shows the left ventricular pressure and heart rate in these control and CK-inhibited hearts. The left ventricular systolic pressure (LVSP) and the spontaneous heart rate were similar in all groups. In contrast, LVEDP was increased in CKinhibited hearts in a dose-dependent fashion ( P Ͻ 0.05), suggesting a diastolic dysfunction in these hearts.
The relationship between intracellular free [MgADP] and the development of diastolic dysfunction is shown in two ways. First, a positive relationship between the increase in [MgADP] and the increase in LVEDP was found using data collected at the end of IA treatment (Fig. 2) . Second, the temporal relationship between [MgADP] and LVEDP during the period of IA infusion was recorded for another group of control and IAtreated hearts (Fig. 3) . For control hearts, infusion of the vehicle did not cause significant changes either in [MgADP] or LVEDP during the 30-min period (Fig. 3, left) . In contrast, for hearts treated with IA, there was a parallel increase in [MgADP] and LVEDP during the infusion period (Fig. 3,  right) . ] c , LVEDP, and P (Fig. 4 A) are presented together with diastolic [Ca 2ϩ ] c and Ca (Fig. 4 B) . These data were obtained simultaneously in the same heart before and after application of a vehicle or IA. In control hearts, infusion of H 2 O as a vehicle did not cause any significant change in LVEDP or [Ca 2ϩ ] c . In hearts treated with IA, a threefold increase in LVEDP was accompanied by a 38% increase in P , demonstrating significant diastolic dysfunction. However, diastolic [Ca 2ϩ ] c was increased by only 16% in these hearts (P Ͻ 0.05), and Ca was not significantly changed by IA.
The effect of IA on the activities of glycolytic enzymes is shown in Table III . The activities of PFK and lactate dehydrogenase (LDH) were unchanged while there was a dosedependent inhibition of GAPdH activity ‫ف(‬ 80%, P Ͻ 0.05) in hearts treated with IA. The glycolytic rate, measured in hearts treated with the highest dose of IA (120 mol), was not different from that of the controls (Table III) . In fact, the remaining 20% GAPdH activity (152 mol/min per g protein) still exceeds the measured glycolytic rate in the control hearts (2.61 mol/min per g protein) by more than 50 times. Taken together, these results indicate that glycolysis is unrestricted even in hearts with partially inhibited GAPdH activity.
Discussion
Sarcomere relaxation depends on dissociation of actin and myosin. The interaction of actin and myosin is regulated in a complex fashion by a number of factors, including intracellular (Fig. 3 A) are compared to the diastolic cytosolic calcium concentration ([Ca 2ϩ ] c ) and Ca (Fig. 3 B) simultaneously obtained from each individual heart before (baseline) and after treatment with either vehicle (ϩH 2 O) or iodoacetamide (ϩIA). Each open square represents data obtained from a heart in the control group, and each open circle represents data obtained from a heart in IA group. The filled symbols are meanϮSE for each measurement.
[MgATP] as well as MgATP hydrolysis products [MgADP] and [Pi] , pH i , and [Ca 2ϩ ] c . Studies on diastolic dysfunction in ischemia reperfusion injury also suggest that MgATP derived from glycolysis might play a role in sustaining diastolic relaxation (9, 24) . The novel finding in this study is that an impairment of myocardial relaxation in an intact heart could be induced by increasing cytosolic [MgADP] with minimal or no detectable changes in other candidate contributors for diastolic dysfunction under well-oxygenated conditions. This observation indicates that failure to maintain a low [MgADP], even at a normal level of [MgATP] and [Pi] , may lead to slowed cross-bridge cycling and, consequently, to impaired myocardial relaxation.
The experimental strategy. The contribution of an altered intracellular high energy phosphate content to diastolic dysfunction has been well documented in myocardial injury by ischemia or hypoxia (25) . However, it has been difficult technically to distinguish the contributions from MgATP depletion, MgADP or Pi accumulation, or changes in pH i to diastolic dysfunction under these conditions. To define the unique contribution of free [MgADP], we used a low dose of IA to selectively inhibit CK activity in the heart. Since the CK reaction (PCr ϩ MgADP ϩ H ϩ <ϭϭ> MgATP ϩ Cr) is one of the major mechanisms for maintaining a low free [MgADP] , inhibition of this reaction leads to increased free [MgADP] in the cell. The specificity of low dose IA for inhibition of creatine kinase has been tested in our previous studies (7, 8) . No functional changes in the primary MgATP synthesis (indices of mitochondrial respiration and the adenylate kinase reaction) and utilization (myofibrillar ATPase) pathways have been found in hearts treated with up to 140 mol of IA (7). Furthermore, myocardial oxygen consumption and baseline contractile function were unaltered in isolated perfused hearts treated with IA (7, 8) . Measurements by 31 P NMR spectroscopy have confirmed that applying a small amount of IA to inhibit the CK activity does not alter [MgATP] at baseline workload in our previous and current studies (7, 8) . Taken together, using a low dose of IA, we were able to achieve an inhibition of the CK reaction without affecting oxidative phosphorylation or glycolysis which allowed a dose-dependent increase in intracellular free [MgADP] without altering [MgATP], [Pi], or pH i in an isolated perfused rat heart. Thus, this strategy provides an opportunity to test the hypothesis that an acute increase in intracellular free [MgADP] alone is sufficient to induce diastolic dysfunction in an intact heart.
[MgADP] and diastolic dysfunction. In hearts treated with increasing doses of IA, we observed up to a threefold increase in LVEDP. A 38% increase in P was also found in IA-treated hearts. Both findings showed the development of diastolic dysfunction in these hearts. It needs to be emphasized that these changes occurred in the absence of alterations in intracellular The mechanism by which MgADP impairs myocardial relaxation has been suggested but has not been completely understood. Previous studies using isolated contractile proteins or skinned fibers have suggested that the detachment of MgADP from the actomyosin complex may be the rate limiting step in cross-bridge cycling, and increase in free [MgADP] may significantly slow down the rate of MgATP binding to actomyosin complex, resulting in impaired relaxation (6, (26) (27) (28) . However, in most of these experiments, [MgADP] was in mM range which is much higher than typical physiological levels in the heart. A study using [MgADP] over the physiological range did not find any alterations in force development of skinned skeletal muscle fibers, but the effect of [MgADP] on fiber relaxation was not investigated (29) . It is, therefore, difficult to extrapolate results from that study to the relationship of [MgADP] and LVEDP observed in this study. It is also possible that different types of striated muscle may yield different results. In support of this, a study showed that cardiac contractile proteins are more sensitive to [MgADP] than skeletal muscle proteins (29) . Consistent with the in vivo results presented here, this same study showed that the sliding velocity of actin filaments on cardiac myosin was significantly reduced by adding MgADP at a concentration as low as 25 M in the presence of 2 mM of MgATP (30) .
More recent studies using smooth muscle actomyosin complex showed that a structural change in myosin occurred during transition from MgADP-bound state to rigor state (31) . It is likely that diastolic dysfunction caused by increased [MgADP] observed in the present study of intact heart is distinct from the myocardial contracture observed in the rigor state, and independent mechanisms may be responsible for impairment of relaxation when [MgATP] decreases. This supports our previous and current observations that impairment of relaxation can be induced by an increase in [MgADP] even though MgATP is not depleted (25, 32) . The increase in free [MgADP] was accompanied by a decrease in [PCr] , raising the possibility that PCr directly affects relaxation. However, PCr is not a substrate of any reaction except the CK reaction. Therefore, it is very likely the only way that changes in the CK activ- ] c and diastolic dysfunction. It is widely recognized that cytosolic calcium overload can lead to diastolic dysfunction, especially in ischemic and hypertrophied myocardium. In the rat, the rate of cytosolic calcium decline during diastole is primarily determined by calcium reuptake by the sarcoplasmic reticulum (SR) Ca 2ϩ -ATPase (33). Our previous study has shown a decrease in the driving force for ATPase reactions (free energy release from MgATP hydrolysis) in hearts treated with IA (8) . Since the calcium reuptake by SR Ca 2ϩ -ATPase requires the highest driving force among all the other ATPase reactions (34), it is essential to define the contribution of [Ca 2ϩ ] c to the diastolic dysfunction observed in this study. Our data suggest that changes of calcium handling at baseline contractile function cannot explain the diastolic dysfunction observed after IA treatment. Specifically, Ca was not changed by IA treatment, even though there was a 38% increase in P . Although there was a 16% increase in diastolic [Ca 2ϩ ] c , this increase was modest relative to the three-fold increase in LVEDP. We thus conclude that changes of calcium handling at baseline did not play a major role in the development of diastolic dysfunction in this model.
Glycolysis and diastolic dysfunction. It has been suggested that MgATP derived from glycolysis in the cytosol is particularly useful for preventing the development of diastolic dysfunction in postischemic myocardium (35) . This finding implies that glycolysis may be a protective mechanism for maintaining normal diastolic function. We found that the in vitro maximal activity of GAPdH, one of the enzymes in glycolytic pathway, was inhibited by up to 80% in hearts treated with IA. Therefore, the glycolytic rate was directly measured in hearts which received the highest dose of IA (120 mol). Compared to the controls, the rate of glycolysis was not different in IA-treated hearts, indicating that the diastolic dysfunction in these hearts was not due to reduced MgATP synthesis from glycolysis. These results also suggest that even large reductions in GAPdH activity in a well-oxygenated heart does not limit glycolytic flux through this portion of the pathway.
Limitations of the study. The intracellular free [MgADP] calculated in this study gives an average cytosolic [MgADP] and may not be equal to the free [MgADP] at the actomyosin cross-bridge. Nevertheless, it is likely that changes in free [MgADP] at the myofibril are determined in large part by the changes in overall intracellular free [MgADP] . It is difficult to compare our results in the intact heart with results obtained from skinned muscle fibers since the disruption of the intracellular environment may have quantitatively changed the actomyosin mechanics in skinned muscle. Moreover, due to the presence of CK and adenylate kinase associated with myofibrils, which function to convert MgADP to MgATP and/or AMP, the free [MgADP] for skinned muscle fibers cannot be quantitatively determined by the amount of MgADP applied to the fibers. Thus, we can compare the relationship between [MgADP] and the development of diastolic dysfunction found in this experiment to previously reported results in skinned muscle studies only qualitatively.
The indo-1 fluorescence study in perfused heart may be limited by the method that collects the signals only from several outer layers of the epicardium. There is a difference between epicardial and endocardial [Ca 2ϩ ] c . It is possible that inhomogeneity in [Ca 2ϩ ] c occurred in IA treated hearts and was not detected by our measurement. However, it has been shown that the difference between epicardial and endocardial [Ca 2ϩ ] c is constant in well-perfused hearts and is not altered by reducing coronary flow up to 50% (19) . Thus, it is likely that changes in epicardial [Ca 2ϩ ] c accurately represent directional changes in [Ca 2ϩ ] c of the whole heart to large extent in our conditions.
In summary, using a low dose of IA to selectively inhibit CK activity in isolated perfused rat hearts, we observed a significant impairment of diastolic function. The rate of glycolysis was not changed by treatment with IA in spite of ‫ف‬ 80% inhibition of GAPdH activity. The modest increase in [Ca 2ϩ ] c found in these hearts cannot explain the severity of diastolic dysfunction. IA caused a dose-dependent increase in intracellular free [MgADP] without changing [MgATP] , [Pi] , or pH i . Furthermore, a close relationship between the development of diastolic dysfunction and the increase in free [MgADP] was observed in these hearts, indicating that increased free [MgADP] is a significant contributor to diastolic dysfunction independent of any changes in other regulators of cross-bridge cycling.
